Rufloxacin
From Wikipedia, the free encyclopedia
|
Rufloxacin
|
|
| Systematic (IUPAC) name | |
| 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro- 7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid | |
| Identifiers | |
| CAS number | 106017-08-7 (hydrochloride) 102052-47-1 (hydrobromide) |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C17H18FN3O3S |
| Mol. mass | 363.406 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Rufloxacin is a quinolone.
|
|||||||||||

